Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1889)	3/6/2008 11:29:25 AM
From: Jibacoa	Read Replies (1) of 3722

EXAS opened with a large UG & is up 55.5% on volume of > 1,660,000 which is > 10x its ADV bigcharts.marketwatch.com It announced yesterday that the its stool-based DNA technology is included in the updated guidelines for colorectal cancer screening released by the ACS. Pre-cancerous lesions & colorectal Cas., shed cells into the stool. EXACT’s stool-based DNA technology can isolate & amplify the DNA from a stool sample & analyze it for DNA mutations and alterations known to be associated with Cas. Colon & rectal cancers are the most deadly cancer among non-smoking men and women in the U.S. & the 2nd most deadly cancer overall. The stock is responding to the news & the CC this morning. It traded earlier above the Dec 14 H of $3.90 & is trying to get off from the DT coming from its Oct H at $6.17 when it made a 52 wks. H Its longer DT comes from its Sep 2003 H ar $18 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next